Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥Free U.S. shipping on orders over $125♥Shipped with tracking within 48 hours♥Pay by Zelle, Cash App or crypto♥Research use only♥

Registered Triptorelin studies

This page lists ClinicalTrials.gov records that name Triptorelin among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.

167Registered studies
22Recruiting
77Completed
33With results posted

167 of 4,477 registered studies · showing 1–25

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

RecruitingPhase 2Triptorelin
NCT ID
NCT06378866
Sponsor
Mayo Clinic
Registry dates
2024-06-03 – 2031-02-28
Enrollment
532 registered participants
Locations
United States
Conditions listed
Recurrent Castration-Sensitive Prostate Carcinoma; Recurrent Prostate Cancer; Castration-resistant Prostate Cancer; Biochemically Recurrent Prostate Carcinoma

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

RecruitingPhase 3Triptorelin
NCT ID
NCT05781217
Sponsor
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Registry dates
2023-03-14 – 2032-12
Enrollment
534 registered participants
Locations
Spain
Conditions listed
Prostate Cancer; Salvage Radiotherapy; Biochemical Recurrence; Androgen Deprivation Therapy +1 more